A recent study determined that vitamin D deficiency is linked with a significant financial burden on hospitals and third party payers.
Vitamin D deficiency is a worldwide problem, affecting at least a third of the population; though, some researchers believe an even greater number of people may be deficient.
Although many individuals who are vitamin D deficient present no symptoms at all, research has shown that low vitamin D status is associated with a prolonged length of hospital stay and an increased risk of mortality in critically ill individuals.
Despite the abundant research on the health implications of vitamin D deficiency in the hospital setting, no studies to date have evaluated the economic implications of this.
Therefore, researchers recently aimed to determine the relationship between vitamin D deficiency (< 18 ng/ml) and intensive care unit (ICU) cost, total hospital cost, ventilator-associated pneumonia (VAP), myocardial infarction (MI) and total hospital stays. Critically ill patients with either VAP, or those who have had a MI (heart attack), may experience an increased length of hospital stay, cost of care and risk of mortality.
Here is what the researchers found:
The researchers concluded,
“Vitamin D3 deficiency is associated with a significant financial impact on hospital and third party payers. Further studies are needed to calculate the full economic impact on hospitals, states, countries, and third party payers.”
Sturges, M. & Cannell, JJ. Does vitamin D deficiency economically impact hospitals and third party payers? Vitamin D Council Blog/Newsletter, November 25, 2015.